4-118338294-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_003619.4(PRSS12):c.523G>A(p.Gly175Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00165 in 1,613,920 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003619.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRSS12 | NM_003619.4 | c.523G>A | p.Gly175Ser | missense_variant | 2/13 | ENST00000296498.3 | NP_003610.2 | |
PRSS12 | XM_011532387.3 | c.523G>A | p.Gly175Ser | missense_variant | 2/9 | XP_011530689.1 | ||
PRSS12 | XM_005263318.5 | c.523G>A | p.Gly175Ser | missense_variant | 2/10 | XP_005263375.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00270 AC: 411AN: 152118Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00201 AC: 505AN: 251002Hom.: 2 AF XY: 0.00199 AC XY: 270AN XY: 135638
GnomAD4 exome AF: 0.00154 AC: 2249AN: 1461684Hom.: 15 Cov.: 31 AF XY: 0.00163 AC XY: 1182AN XY: 727136
GnomAD4 genome AF: 0.00270 AC: 411AN: 152236Hom.: 3 Cov.: 32 AF XY: 0.00254 AC XY: 189AN XY: 74426
ClinVar
Submissions by phenotype
Intellectual disability, autosomal recessive 1 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | PRSS12: BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 22, 2015 | - - |
PRSS12-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 05, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at